A universal vaccine being developed in the UK that should be effective against various strains of the coronavirus may hit the market this year, according to The Daily Telegraph.
Two teams of researchers in the UK are working on vaccines the use of which allows the body's immune system not to recognize the coronavirus protein, whose structure is more susceptible to mutations. The latter change much less frequently, allowing new vaccines to stay effective for longer.
Such drugs are being developed by the University of Nottingham, as well as the private company Scancell, which plans to start clinical trials of its vaccines in the second half of the year in order to get positive results from the respective tests on mice.
Researchers in Belgium, France, the US, and a number of other countries are also working on vaccines that remain effective when new coronavirus strains emerge.

Armenian parliamentary standing committee approves bill on ratifying EAEU-Serbia free trade deal
Today, 12:54-
Grigory Karasin highlights OSCE Minsk Group Co-Chairs’ role in NK conflict settlement
Today, 12:52 -
Armenia restricts use of AstraZeneca vaccine to over 55s
Today, 12:51 -
Return of POWs a priority for Russian side, Ambassador says
Today, 12:48 -
Armenia set to launch COVID-19 vaccinations
Today, 12:46 -
ADB approves $1.3 million to support digital platform to help improve land resources management in Armenia
Today, 12:37 -
PM Pashinyan is now de facto traitor, nation-destroyer, says Armenia ex-deputy defense minister
Yesterday, 16:12 -
Armenia Ambassador Arman Navasardyan dies aged 82
Yesterday, 13:46 -
Political scientist: Armenia ruling force has no chance of winning if other forces run successful election campaign
Yesterday, 13:43